Ads
related to: sanofi- Learn About T1D Treatment
Discover T1D Treatment for
Appropriate Patients
- How To Screen For T1D
Learn How To Screen
Patients For T1D
- Patient Support
Discover Support For Patients
On Their T1D Journey
- Patient Criteria
Learn How Patients Qualify
For This T1D Treatment
- Learn About T1D Treatment
Search results
Will Zantac ruling make Delaware a mass torts magnet?
Reuters· 2 days agoIf you are mass torts lawyer, you should be paying attention to a trend that has emerged in...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 5 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
Delaware judge lets more than 70,000 Zantac lawsuits go forward By Reuters
Investing.com· 2 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 1 day agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via AOL· 5 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 5 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Sanofi’s Chronic Lung Disease Drug Gets EU Regulator Backing
Bloomberg· 5 days agoSanofi’s Dupixent is close to being approved in Europe for use in helping patients with a chronic...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Morningstar· 5 days agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent, but stressed that there ...
Lower Eczema Risk: Another Reason to Reduce Sodium Intake?
Medscape· 11 hours agoIn a study of adults, an increase of 1 g in estimated 24-hour urinary sodium excretion was...